Sandostatin Lar 10 mg

Sandostatin LAR 10 mg is a sustained-release powder for suspension, used for long-term management of conditions like acromegaly and certain gastrointestinal disorders. This intramuscular injection contains octreotide acetate, a somatostatin analog.

Sandostatin LAR 10 mg is primarily used to manage symptoms associated with acromegaly, a condition where the body produces too much growth hormone. It is also used to control symptoms of certain gastrointestinal disorders, such as diarrhea and flushing associated with metastatic neuroendocrine tumors. Octreotide acetate works by mimicking the effects of natural somatostatin, a hormone that regulates various bodily functions.

Common effects of Sandostatin LAR 10 mg may include injection site reactions, nausea, abdominal pain, and changes in blood sugar levels. Some users may experience fatigue or headache. These effects vary and are not experienced by everyone.

Sandostatin LAR 10 mg should be administered by a healthcare professional. It is important to inform your healthcare provider about any allergies or medical conditions before use. Regular monitoring may be required to assess the effectiveness and safety of the treatment.

Sandostatin LAR 10 mg may interact with other medications, including those metabolized by the liver. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and certain foods may also affect the efficacy of the treatment.